FM
FMR LLC cut its AVTX stake below 5%
FMR LLC reported owning 0.9% of Avalo Therapeutics, Inc. (AVTX) (474,359 shares) in a Schedule 13G filed Nov 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 6, 2026
- Source
- Schedule 13G